135 related articles for article (PubMed ID: 22540389)
1. Topical cis-urocanic acid attenuates oedema and erythema in acute and subacute skin inflammation in the mouse.
Laihia JK; Taimen P; Kujari H; Leino L
Br J Dermatol; 2012 Sep; 167(3):506-13. PubMed ID: 22540389
[TBL] [Abstract][Full Text] [Related]
2. Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis.
Peltonen JM; Pylkkänen L; Jansén CT; Volanen I; Lehtinen T; Laihia JK; Leino L
Acta Derm Venereol; 2014 Jul; 94(4):415-20. PubMed ID: 24284985
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin ointment, a new treatment for skin inflammatory conditions.
Adami M; Prudente Ada S; Mendes DA; Horinouchi CD; Cabrini DA; Otuki MF
J Dermatol Sci; 2012 May; 66(2):127-35. PubMed ID: 22455735
[TBL] [Abstract][Full Text] [Related]
4. The role of cis-urocanic acid in UVB-induced suppression of contact hypersensitivity.
Kondo S; Sauder DN; McKenzie RC; Fujisawa H; Shivji GM; El-Ghorr A; Norval M
Immunol Lett; 1995 Dec; 48(3):181-6. PubMed ID: 8867849
[TBL] [Abstract][Full Text] [Related]
5. Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species.
Rinaldi M; Moroni P; Leino L; Laihia J; Paape MJ; Bannerman DD
J Dairy Sci; 2006 Nov; 89(11):4188-201. PubMed ID: 17033005
[TBL] [Abstract][Full Text] [Related]
6. cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha.
Kurimoto I; Streilein JW
J Immunol; 1992 May; 148(10):3072-8. PubMed ID: 1578133
[TBL] [Abstract][Full Text] [Related]
7. Topical valrubicin application reduces skin inflammation in murine models.
Hauge E; Christiansen H; Rosada C; de Darkó E; Dam TN; Stenderup K
Br J Dermatol; 2012 Aug; 167(2):288-95. PubMed ID: 22458650
[TBL] [Abstract][Full Text] [Related]
8. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Yasukawa K; Iida T; Fujimoto Y
J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
[TBL] [Abstract][Full Text] [Related]
9. The degradation of L-histidine and trans- and cis-urocanic acid by bacteria from skin and the role of bacterial cis-urocanic acid isomerase.
Hug DH; Dunkerson DD; Hunter JK
J Photochem Photobiol B; 1999 May; 50(1):66-73. PubMed ID: 10443033
[TBL] [Abstract][Full Text] [Related]
10. Effects of intramammary infusion of cis-urocanic acid on mastitis-associated inflammation and tissue injury in dairy cows.
Bannerman DD; Rinaldi M; Vinyard BT; Laihia J; Leino L
Am J Vet Res; 2009 Mar; 70(3):373-82. PubMed ID: 19254150
[TBL] [Abstract][Full Text] [Related]
11. Urocanic acid enhances IL-10 production in activated CD4+ T cells.
Holán V; Kuffová L; Zajícová A; Krulová M; Filipec M; Holler P; Jancárek A
J Immunol; 1998 Oct; 161(7):3237-41. PubMed ID: 9759837
[TBL] [Abstract][Full Text] [Related]
12. A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice.
Hart PH; Grimbaldeston MA; Swift GJ; Hosszu EK; Finlay-Jones JJ
Photochem Photobiol; 1999 Nov; 70(5):807-12. PubMed ID: 10568173
[TBL] [Abstract][Full Text] [Related]
13. Histamine and cis-urocanic acid augment tumor necrosis factor-alpha mediated induction of keratinocyte intercellular adhesion molecule-1 expression.
Mitra RS; Shimizu Y; Nickoloff BJ
J Cell Physiol; 1993 Aug; 156(2):348-57. PubMed ID: 8102141
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tumor antigen presentation by urocanic acid.
Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD
J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic treatment of mice with urocanic acid isomers.
el-Ghorr AA; Norval M
Photochem Photobiol; 1997 May; 65(5):866-72. PubMed ID: 9155259
[TBL] [Abstract][Full Text] [Related]
16. Regulation of stimulated cyclic AMP synthesis by urocanic acid.
Bouscarel B; Noonan F; Ceryak S; Gettys TW; Phillips TM; DeFabo EC
Photochem Photobiol; 1998 Mar; 67(3):324-31. PubMed ID: 9523531
[TBL] [Abstract][Full Text] [Related]
17. The effect of histamine receptor antagonists on immunosuppression induced by the cis-isomer of urocanic acid.
Norval M; Gilmour JW; Simpson TJ
Photodermatol Photoimmunol Photomed; 1990 Dec; 7(6):243-8. PubMed ID: 1983293
[TBL] [Abstract][Full Text] [Related]
18. Isomerization of urocanic acid after ultraviolet radiation is influenced by skin pigmentation.
de Fine Olivarius F; Wulf HC; Crosby J; Norval M
J Photochem Photobiol B; 1999 Jan; 48(1):42-7. PubMed ID: 10205877
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.
Moodycliffe AM; Norval M; Kimber I; Simpson TJ
Immunology; 1993 Aug; 79(4):667-72. PubMed ID: 8406594
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific inhibition of human epidermal cell interleukin-1 secretion and HLA-DR expression by cis-urocanic acid.
Räsänen L; Jansén CT; Reunala T; Morrison H
Photodermatol; 1987 Aug; 4(4):182-6. PubMed ID: 3501579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
